We are live on ! Find out more
FT

Fiduciary Trust Portfolio holdings

AUM $8.46B
1-Year Est. Return 21.38%
This Fund
S&P 500
This Quarter Est. Return
-13.72%
1 Year Est. Return
+21.38%
3 Year Est. Return
+65.44%
5 Year Est. Return
+79.3%
10 Year Est. Return
+269.63%
AUM
$4.75B
AUM Growth
-$830M
Cap. Flow
-$6.93M
Cap. Flow %
-0.15%
Top 10 Hldgs %
38.44%
Holding
690
New
28
Increased
151
Reduced
316
Closed
63

Sector Composition

Rank Sector Weight
1 Technology 15.3%
2 Healthcare 11.51%
3 Consumer Discretionary 11.08%
4 Financials 5.98%
5 Consumer Staples 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMB icon
601
Williams Companies
WMB
$86.6B
$207K ﹤0.01%
6,632
LVS icon
602
Las Vegas Sands
LVS
$31.6B
$206K ﹤0.01%
6,134
-11
-0.2% -$381
IP icon
603
International Paper
IP
$22.5B
$203K ﹤0.01%
4,864
KMI icon
604
Kinder Morgan
KMI
$70.6B
$202K ﹤0.01%
12,035
-415
-3% -$7.77K
VBK icon
605
Vanguard Small-Cap Growth ETF
VBK
$23.3B
$202K ﹤0.01%
1,027
+90
+10% +$19.5K
NOK icon
606
Nokia
NOK
$51.8B
$151K ﹤0.01%
32,574
-23,230
-42% -$116K
FHTX icon
607
Foghorn Therapeutics
FHTX
$305M
$148K ﹤0.01%
10,879
NUV icon
608
Nuveen Municipal Value Fund
NUV
$1.9B
$145K ﹤0.01%
16,233
TSVT
609
DELISTED
2seventy bio
TSVT
$145K ﹤0.01%
11,017
MCI
610
Barings Corporate Investors
MCI
$343M
$140K ﹤0.01%
10,437
NRIX icon
611
Nurix Therapeutics
NRIX
$2.43B
$136K ﹤0.01%
10,717
EXG icon
612
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.92B
$120K ﹤0.01%
+15,600
New +$135K
ESBA icon
613
Empire State Realty Series ES
ESBA
$1.56B
$114K ﹤0.01%
16,000
TEF
614
DELISTED
Telefonica
TEF
$88K ﹤0.01%
17,000
-305
-2% -$1.49K
RYTM icon
615
Rhythm Pharmaceuticals
RYTM
$7.28B
$83K ﹤0.01%
+20,000
New +$109K
IRON icon
616
Disc Medicine
IRON
$2.85B
$68K ﹤0.01%
+1,350
New +$59.7K
JNCE
617
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$64K ﹤0.01%
21,185
QVCGA
618
DELISTED
QVC Group Inc Series A
QVCGA
$58K ﹤0.01%
403
UEC icon
619
Uranium Energy
UEC
$4.9B
$51K ﹤0.01%
16,470
SREV
620
DELISTED
ServiceSource International, Inc.
SREV
$49K ﹤0.01%
33,403
MVIS icon
621
Microvision
MVIS
$88.8M
$38K ﹤0.01%
10,000
DNTH icon
622
Dianthus Therapeutics
DNTH
$5.71B
$37K ﹤0.01%
1,910
AGTC
623
DELISTED
Applied Genetic Technologies Corporation
AGTC
$31K ﹤0.01%
40,000
UROY
624
Uranium Royalty Corp
UROY
$402M
$30K ﹤0.01%
13,370
CARM
625
DELISTED
Carisma Therapeutics
CARM
$17K ﹤0.01%
1,035

Similar funds

Fiduciary Trust's Q2 2022 Portfolio in Review

As of Q2 2022, Fiduciary Trust held 690 positions worth $4.75B, down 15% from $5.58B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Fiduciary Trust's Q2 2022 filing shows 28 new, 151 increased, 316 reduced and 63 closed positions. Its largest new stake was Pacer US Cash Cows 100 ETF: 85,000 shares worth $3.66M. The largest sale was iShares Core S&P 500 ETF, an estimated $7.77M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Fiduciary Trust's largest Q2 2022 buy was Pacer US Cash Cows 100 ETF: 85,000 shares worth $3.66M.
  • Fiduciary Trust added most to JPMorgan Ultra-Short Municipal Income ETF in Q2 2022, an estimated $40M increase.
  • Fiduciary Trust's biggest Q2 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $7.77M.
  • Fiduciary Trust fully exited BlackRock Health Sciences Trust II in Q2 2022, selling an estimated $2.86M.
  • Fiduciary Trust's ten largest holdings make up 38% of its $4.75B portfolio in Q2 2022.
  • Fiduciary Trust opened 28 new positions and closed 63 in Q2 2022.
  • Fiduciary Trust's portfolio value fell 15% quarter-over-quarter to $4.75B.

Based on Fiduciary Trust's 13F filing for Q2 2022, filed 12 Aug 2022.